FDA PMA FDA Class 3 Approved 🇺🇸 United States

Implanted Phrenic Nerve Stimulator For Central Sleep Apnea

PMA: P160039 · Supplement: S011 · Decision May 7, 2025
Classifications
1
FEI Numbers
3
Registration Numbers
3

Basic Information

Device Name
Implanted Phrenic Nerve Stimulator For Central Sleep Apnea
Trade Name
remede System
PMA Number
P160039
Supplement Number
S011
Device Class
FDA Class 3
Product Code
PSR
Generic Name
Implanted phrenic nerve stimulator for central sleep apnea
Medical Specialty
Unknown
Advisory Committee
Anesthesiology
Decision
Approved
Decision Code
APPR
Decision Date
May 7, 2025
Date Received
February 6, 2025
Supplement Type
Normal 180 Day Track
Supplement Reason
Labeling Change - Indications/instructions/shelf life/tradename
Expedited Review
N

Advisory Committee Statement

revised MR Conditional labeling of the remed?® System to remove the requirement to program the IPG to OFF mode prior to MRI scanning as the device automatically enters and remains in the Therapy Disabled (Magnet Mode) state during MRI exposure

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
PSR Implanted Phrenic Nerve Stimulator For Central Sleep Apnea